Labshake search
Citations for Invivogen :
201 - 250 of 1591 citations for 2' Chloro 4 5 5 dimethyl 1 3 dioxan 2 yl butyrophenone since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2021Quote: ... Mice (n=3-5) were vaccinated subcutaneously (s.c) once with 5 μg of spike combined with 100 μg of Alhydrogel (Alum; Invivogen, California, USA) or 100 μg Alhydroxiquim-II and boosted three weeks after the first vaccination ...
-
bioRxiv - Immunology 2024Quote: ... 2.5 μM, and 5 μM) or with the TLR8 inhibitor CU-CPT9a (2.5 μM, 5 μM, and 10 μM) (InvivoGen, #inh-cc9a) and incubated at 37 °C ...
-
bioRxiv - Bioengineering 2023Quote: ... or ss-ppp-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (Catalog Code, lyec-12, InvivoGen), following the manufacturer’ ss instructions ...
-
bioRxiv - Bioengineering 2023Quote: ... or ss-miRNA-21 (2, 4 or 8 µg/ml) were transfected into the cells using LyoVec™ (InvivoGen, Catalog Code. lyec-12, InvivoGen) following the manufacturer’ ss instructions ...
-
bioRxiv - Immunology 2024Quote: ... Palmitoyl-3-CysSerLys-4 (Pam3CSK4) (InvivoGen, tlrl-pms, 100 ng/ml); 7-amino-4 chloromethylcoumarin (CMAC ...
-
bioRxiv - Biochemistry 2020Quote: ... supplemented with 2 μg/ml puromycin (InvivoGen), 10% fetal bovine serum (FBS ...
-
bioRxiv - Cell Biology 2020Quote: ... or 2 μg ISD (InvivoGen, CA, USA) by lipofectamine 2000 reagent (Thermo Fisher Scientific ...
-
bioRxiv - Immunology 2020Quote: ... 2 μg of either poly-IC (Invivogen), 5’-ppp RNA (Invivogen) ...
-
bioRxiv - Cell Biology 2021Quote: ... selective inhibitor of JAK1/2 (10uM) (Invivogen), and Butylated hydroxylanisole (BHA) ...
-
bioRxiv - Immunology 2020Quote: ... and NOD1/2 inhibitor GEF (Gefitinib, Invivogen) were added to the cell cultures along with either solution buffer (control ...
-
bioRxiv - Biochemistry 2023Quote: ... and normocin antibiotic (InvivoGen #ant-nr-2) at 37°C in 5% CO2 ...
-
bioRxiv - Immunology 2023Quote: ... 2 μg/mL LPS (tlrl-peklps, InvivoGen), 10 ng/mL IL-4 (574302 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.1mg/mL Normocin (Invivogen ant-nr-2), in Advanced DMEM/F12 (Gibco 12634010 ...
-
bioRxiv - Neuroscience 2024Quote: ... supplemented with primocin (Invivogen, #ant-pm-2), G418 (50 μg/ml ...
-
bioRxiv - Microbiology 2022Quote: ... and poly I:C (2 µg/ml, InvivoGen) to facilitate the presentation of long peptides by antigen presenting cells (Schuhmacher et al. ...
-
bioRxiv - Microbiology 2023Quote: ... β-D-ADP-heptose (2 mM, Invivogen) and β-L-ADP-heptose (J&K ...
-
bioRxiv - Cell Biology 2024Quote: ... alum hydroxide (Invivogen, cat. #21645-51-2), monosodium urate crystals (Invivogen ...
-
bioRxiv - Neuroscience 2021Quote: ... resiquimod (2 mg/kg of a 1 mg/ ml solution in PBS, Invivogen tlrl-r848), were administered subcutaneously on E12.5 between 9:00-11:00 am and their conditions were monitored to ensure that there was no sign of any severe sickness symptoms or abnormalities.
-
bioRxiv - Molecular Biology 2024Quote: ... cells were selected with complete media containing 2 μg/ml puromycin (InvivoGen, ant-pr-1) for 10 days and maintained with 0.5 μg/mL Puromycin ...
-
bioRxiv - Immunology 2024Quote: ... 50 μM 2-mercaptoethanol (Fisher; 31350010) and 100 μg/ml Normocin (InvivoGen; ant-nr-1)) ...
-
RORγt-dependent antigen-presenting cells direct regulatory T cell-mediated tolerance to food antigenbioRxiv - Immunology 2024Quote: ... with intraperitoneal injections of 100 μg of OVA mixed with 1 mg of Alum (1:1; Alhydrogel® adjuvant 2%; vac-alu-50; InvivoGen). Seven days after the final sensitization ...
-
bioRxiv - Microbiology 2022Quote: ... Cells were then selected with Blasticidin at 5 μg/mL and Puromycin (1 μg/mL, Invivogen, USA) to select for cells stably expressing both dCas9 and the sgRNAs ...
-
bioRxiv - Microbiology 2023Quote: ... cells were treated with 5 μg/mL puromycin (InvivoGen, San Diego, CA, USA, Cat# ant-pr-1). After 1 week of incubation ...
-
bioRxiv - Immunology 2023Quote: ... Serum flow-through was then passed through 1 mL of Peptide M agarose (InvivoGen, gel-pdm-5) affinity column in gravity mode ...
-
bioRxiv - Microbiology 2023Quote: ... The cells were cultured for 2 weeks in the presence of 1 µg/mL puromycin (ant-pr-1, InvivoGen). The cells were single-cell-cloned using a limiting dilution method ...
-
bioRxiv - Systems Biology 2020Quote: ... followed by 5 hours with 200ng/ml LPS (Invivogen).
-
bioRxiv - Cell Biology 2021Quote: ... and 5 µg/ml Plasmocin (Cat# ant-mpp, InvivoGen), in a 37°C ...
-
bioRxiv - Cancer Biology 2022Quote: ... or Blasticidin (5-10 µg/ml; Invivogen; ant-bl).
-
bioRxiv - Immunology 2022Quote: ... and R848 (#tlrl-r848-5) were purchased from Invivogen. Sendai virus (SeV ...
-
bioRxiv - Immunology 2022Quote: ... 5 μg HA protein combined with either Alum (InvivoGen) or AddaVax (InvivoGen ...
-
bioRxiv - Immunology 2021Quote: ... at 5 μM or the STING agonist cGAMP (Invivogen) or the TLR3 agonist polyinosinic-polycytidylic acid (poly(I:C) ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were selected in puromycin (5 µg/ml, InvivoGen) for 48h ...
-
bioRxiv - Biochemistry 2023Quote: ... for two weeks or 5 μg/ml Puromycin (Invivogen) for 5 days to establish stable cell lines expressing the desired shRNA or sgRNA ...
-
bioRxiv - Bioengineering 2024Quote: ... and 100 µg/mL G418 (InvivoGen, ant-gn-5). For both mouse and human podocytes ...
-
bioRxiv - Immunology 2024Quote: ... supplemented every 48 hours with MCC950 (5 μM, Invivogen). NLRP3 inflammasome activation by Nigericin in BMDMs required a priming step where BMDMs were incubated with LPS (10 ng/ml ...
-
bioRxiv - Biochemistry 2022Quote: ... and 50 μg/ml Zeocin (Invivogen, #ant-zn-5). MEFs were grown in DMEM containing 10% (v/v ...
-
bioRxiv - Cell Biology 2022Quote: ... Antibiotic concentrations used were: 5 μg/mL blasticidin (InvivoGen), 200 μg/mL hygromycin (Merck) ...
-
bioRxiv - Immunology 2022Quote: ... 5’ppp dsRNA was purchased from Invivogen (tlrl-3prna). 5’-di- and triphosphate ssRNA oligonucleotides were synthesized as previously described (Goubau et al. ...
-
bioRxiv - Evolutionary Biology 2023Quote: ... and 5 μg/ml plasmocin (InvivoGen, San Diego, CA), and cells were cultured in a humidified incubator with 5% CO2 at 37 °C ...
-
bioRxiv - Biophysics 2023Quote: ... and 5 mg/ml blasticidin (Invivogen #ant-bl-5b) at 37 °C ...
-
bioRxiv - Immunology 2024Quote: ... and PolyIC (Invivogen Cat. tlrl-PIC-5 40µg/ml) 16 hours before pulsing with the peptide of interest and cultured with autologous T cells in a MoDC:T ratio of 1:10 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 5 ug/ml plasmocin prophylactic (Invivogen, ant-mpp). hTERT-RPE1 and derived cells were cultured in a 1:1 mixture of Dulbecco’s Modified Eagle’s Medium (DMEM ...
-
bioRxiv - Genetics 2024Quote: ... and 400 µg/mL G418 (Invivogen ant-gn-5), respectively ...
-
bioRxiv - Evolutionary Biology 2024Quote: ... and 5 μg/ml plasmocin (InvivoGen, San Diego, CA), and cultured in a humidified incubator with 5% CO2 at 37 °C ...
-
bioRxiv - Immunology 2022Quote: ... 2 mM (peritoneal macrophages) ATP or 50 µM (THP-1 differentiated macrophages) R837 (InvivoGen, tlrl-imqs) for 30-60 min ...
-
bioRxiv - Microbiology 2023Quote: ... Envelope defective virus was pseudotyped with HU-1 SARS-CoV-2 Spike protein (pLV-Spike, Invivogen) and used for single round infection assays ...
-
bioRxiv - Microbiology 2023Quote: ... B.1.1.529/BA.1 SARS-CoV-2 spike plasmid (plv-spike-v11) was obtained from InvivoGen and subcloned into pcDNA3.1-puro ...
-
bioRxiv - Cancer Biology 2023Quote: ... Antibiotic selection was applied two days after transfection (2 μg/mL puromycin (#ant-pr-1, Invivogen) for 3 days).
-
bioRxiv - Immunology 2022Quote: ... Mice in the RBD + aluminum hydroxide condition received 10 µg of recombinant monomeric SARS-CoV-2 RBD protein formulated with 100 µg of Alhydrogel adjuvant 2% (Invivogen). Mice in the PBS vaccination group received phosphate-buffered saline (PBS ...
-
bioRxiv - Cancer Biology 2021Quote: ... We started puromycin selection (2 μg/ml) (InvivoGen) 48 hours post-transduction for at least two days or until no survival cell was observed from the control group ...